Pharmabiz21d
Chugai Pharma to transfer future marketing of anti-cancer agent, Tarceva tablets 25, 100 & 150 in Japan to Cheplapharm
Chugai in-licensed Tarceva from Roche and is the marketing authorization holder in Japan. Chugai has been marketing Tarceva and providing information in Japan since 2007. In consideration of the ...
Morningstar12d
X4 Pharmaceuticals Announces EMA Validation of Marketing Authorization Application (MAA) for Mavorixafor for the Treatment of WHIM Syndrome
today announced that its Marketing Authorization Application (MAA) for mavorixafor for the treatment of WHIM syndrome (warts, hypogammaglobulinemia, infections and myelokathexis), a rare primary ...
Pharmaceutical Technology1y
Abacus Medicine Pharma Services and Laboratoires Ctrs Extend Partnership to Improve Access to Orphacol® in Spain
Abacus Medicine Pharma Services (AMPS) and Laboratoires CTRS, marketing authorization holder of Orphacol®, are proud to announce a strategic ...